Skip to main content
. 2022 Oct 10;5(10):e2235856. doi: 10.1001/jamanetworkopen.2022.35856

Table 1. Participant Characteristics at Time of Fracture by Multimorbidity Clusters.

Characteristics Multimorbidity disease clustera
Men (n = 95 372) Women (n =212 498)
Low multimorbidity Cardiovascular Diabetic Malignant Hepatic and/or inflammatoryb Low multimorbidity Cardiovascular Diabetic Malignant
All 57 711 (60.5) 22 589 (23.7) 5315 (5.6) 4907 (5.1) 4850 (5.1) 141 222 (66.5) 49 932 (23.5) 10 697 (5.0) 10 647 (5.0)
Age at fracture, mean (SD), y 70.2 (11.3) 78.2 (9.8) 72.0 (9.3) 72.8 (9.4) 70.6 (10.3) 73.1 (11.3) 80.2 (9.7) 75.5 (9.6) 73.2 (9.7)
Comorbidities, median (IQR) No. 1.0 (0-1.0) 4.0 (3.0-5.0) 5.0 (4.0-7.0) 3.0 (2.0-4.0) 4.0 (3.0-5.0) 0 (0-1.0) 3.0 (2.0-4.0) 4.0 (3.0-6.0) 3.0 (2.0-3.0)
No. of comorbidities
0 26 632 (46.1) 0 0 0 0 73 740 (52.2) 0 0 0
1 20 156 (34.9) 0 0 0 272 (5.6) 53 124 (37.6) 390 (0.8) 0 0
2 9874 (17.1) 3612 (16.0) 302 (5.7) 1875 (38.2) 802 (16.5) 13 812 (9.8) 12 911 (25.9) 1650 (15.4) 4234 (39.8)
3-4 1049 (1.8) 12 569 (55.6) 1602 (30.1) 2412 (49.1) 2206 (45.5) 546 (0.4) 26 206 (52.5) 3946 (36.9) 5418 (50.9)
≥5 0 6408 (28.4) 3411 (64.2) 620 (12.6) 1570 (32.4) 0 10 425 (20.9) 5101 (47.7) 995 (9.3)
Specific comorbiditiesc
Myocardial infarction 2139 (3.7) 6675 (29.5) 1434 (27.0) 335 (6.8) 568 (11.7) 1990 (1.4) 9322 (18.7) 2111 (19.7) 258 (2.4)
Congestive heart failure 714 (1.2) 9799 (43.4) 1872 (35.2) 498 (10.1) 887 (18.3) 2044 (1.4) 16 261 (32.6) 2968 (27.7) 423 (4.0)
Peripheral vascular disease 2071 (3.6) 4833 (21.4) 1947 (36.6) 445 (9.1) 604 (12.5) 3463 (2.5) 7247 (14.5) 2262 (21.1) 544 (5.1)
Cerebrovascular disease 7266 (12.6) 9862 (43.7) 2070 (38.9) 584 (11.9) 1252 (25.8) 10 250 (7.3) 19 633 (39.3) 3868 (36.1) 2665 (25.0)
Cardiac valvular disease 115 (0.2) 2097 (9.3) 309 (5.8) 110 (2.2) 181 (3.7) 296 (0.2) 4456 (8.9) 520 (4.9) 155 (1.5)
Cardiac arrhythmias 1302 (2.3) 8854 (39.2) 1184 (22.3) 357 (7.3) 748 (15.4) 2388 (1.7) 14 793 (29.6) 1766 (16.5) 460 (4.3)
Diabetes without chronic complications 2632 (4.6) 2907 (12.9) 5146 (96.8) 621 (12.7) 779 (16.1) 3737 (2.6) 3343 (6.7) 10 293 (96.2) 1171 (11.0)
Diabetes with chronic complications 210 (0.4) 66 (0.3) 4744 (89.3) 12 (0.2) 135 (2.8) 227 (0.2) 0 5862 (54.8) 6 (0.1)
Any malignant neoplasm except skin 8210 (14.2) 4997 (22.1) 1156 (21.7) 4907 (100) 1109 (22.9) 16 896 (12.0) 7857 (15.7) 3008 (28.1) 10 647 (100)
Metastatic solid tumor 188 (0.3) 175 (0.8) 186 (3.5) 3324 (67.7) 167 (3.4) 386 (0.3) 309 (0.6) 222 (2.1) 5936 (55.7)
Rheumatic or rheumatoid arthritis or collagen vascular diseases 445 (0.8) 186 (0.8) 265 (5.0) 39 (0.8) 2390 (49.3) 5983 (4.2) 4931 (9.9) 1039 (9.7) 794 (7.5)
Mild liver disease 484 (0.8) 93 (0.4) 278 (5.2) 88 (1.8) 1976 (40.7) 982 (0.7) 1706 (3.4) 552 (5.2) 356 (3.3)
Moderate or severe liver disease 32 (0.1) 8 (0.03) 100 (1.9) 16 (0.3) 1052 (21.7) 53 (0.03) 673 (1.3) 203 (1.9) 136 (1.3)
Hypertension 2250 (3.9) 8779 (38.9) 2526 (47.5) 1078 (22.0) 963 (19.9) 6167 (4.4) 21 136 (42.3) 4734 (44.3) 1679 (15.8)
Chronic pulmonary disease 4789 (8.3) 7394 (32.7) 1233 (23.2) 864 (17.6) 1191 (24.5) 10 331 (7.3) 14 276 (28.6) 2328 (21.8) 2168 (20.4)
Pulmonary circulation disorders 138 (0.2) 671 (3.0) 109 (2.1) 106 (2.2) 69 (1.4) 158 (0.1) 1542 (3.1) 184 (1.7) 169 (1.6)
Dementia 3487 (6.0) 4168 (18.5) 575 (10.8) 102 (2.1) 439 (9.1) 8326 (5.9) 10 455 (20.9) 1146 (10.7) 388 (3.6)
Psychoses 164 (0.3) 163 (0.7) 26 (0.5) 13 (0.3) 35 (0.7) 203 (0.1) 439 (0.9) 56 (0.5) 29 (0.3)
Depression 283 (0.5) 1487 (6.6) 219 (4.1) 87 (1.8) 278 (5.7) 397 (0.3) 5067 (10.1) 420 (3.9) 312 (2.9)
Paralysis or hemiparaplegia 344 (0.6) 340 (1.5) 94 (1.8) 97 (2.0) 66 (1.4) 402 (0.3) 423 (0.8) 86 (0.8) 141 (1.3)
Neurological disorders 1881 (3.3) 2108 (9.3) 265 (5.0) 105 (2.1) 344 (7.1) 2372 (1.7) 3227 (6.5) 357 (3.3) 302 (2.8)
Peptic ulcer disease 2197 (3.8) 3575 (15.8) 733 (13.8) 475 (9.7) 1064 (21.9) 4307 (3.0) 7839 (15.7) 1284 (12.0) 816 (7.7)
Chronic renal disease 357 (0.6) 3277 (14.5) 1362 (25.6) 377 (7.7) 386 (8.0) 428 (0.3) 3634 (7.3) 1749 (16.3) 451 (4.2)
Hypothyroidism 82 (0.1) 325 (1.4) 83 (1.6) 40 (0.8) 46 (0.9) 794 (0.6) 2645 (5.3) 625 (5.8) 230 (2.2)
Coagulopathy 46 (0.1) 257 (1.1) 51 (1.0) 62 (1.3) 112 (2.3) 108 (0.1) 407 (0.8) 96 (0.9) 70 (0.7)
Obesity 135 (0.2) 425 (1.9) 594 (11.2) 62 (1.3) 103 (2.1) 447 (0.3) 1040 (2.1) 1223 (11.4) 319 (3.0)
Unintended weight loss 60 (0.1) 321 (1.4) 70 (1.3) 75 (1.5) 96 (2.0) 89 (0.1) 923 (1.8) 90 (0.8) 89 (0.8)
Fluid or electrolyte disorders 634 (1.1) 3055 (13.5) 507 (9.5) 208 (4.2) 443 (9.1) 937 (0.7) 8773 (17.6) 890 (8.3) 556 (5.2)
Anemia 118 (0.2) 974 (4.3) 175 (3.3) 106 (2.2) 213 (4.4) 285 (0.2) 2562 (5.1) 301 (2.8) 200 (1.9)
Alcohol abuse 215 (0.4) 72 (0.3) 117 (2.2) 24 (0.5) 1409 (29.1) 72 (0.1) 794 (1.6) 147 (1.4) 86 (0.8)
Drug abuse 45 (0.1) 71 (0.3) 18 (0.3) 4 (0.1) 58 (1.2) 29 (0.02) 273 (0.5) 18 (0.2) 10 (0.1)
HIV/AIDS 27 (0.05) 17 (0.1) 3 (0.1) 5 (0.1) 8 (0.2) 7 (0.01) 2 (0.004) 2 (0.02) 5 (0.05)
a

Data are presented as No. (%), unless indicated otherwise.

b

Data were collected for men only.

c

Includes not only chronic diseases that require hospitalization, but also those documented as either secondary diagnoses or at outpatient or emergency visits.